Prognostic role of clinical, pathological and biological characteristics in patients with locally advanced breast cancer
1998

Prognostic Factors in Locally Advanced Breast Cancer

Sample size: 42 publication Evidence: moderate

Author Information

Author(s): AH Honkoop, PJ van Diest, JS de Jong, SC Linn, G Giaccone, K Hoekman, J Wagstaff, HM Pinedo

Primary Institution: University Hospital Vrije Universiteit

Hypothesis

What clinical, pathological, and biological characteristics predict outcomes in patients with locally advanced breast cancer treated with neoadjuvant chemotherapy?

Conclusion

The study suggests that more chemotherapy cycles and a better pathological response are associated with improved survival in patients with locally advanced breast cancer.

Supporting Evidence

  • More chemotherapy cycles were related to better disease-free survival.
  • A better pathological response to chemotherapy was associated with improved overall survival.
  • High levels of Ki-67 staining after chemotherapy correlated with worse prognosis.
  • Co-expression of P-gp and p53 was linked to poorer outcomes.

Takeaway

This study looked at women with advanced breast cancer and found that getting more chemotherapy can help them live longer.

Methodology

Patients received neoadjuvant chemotherapy followed by mastectomy and radiotherapy, with a follow-up period of 32 months.

Potential Biases

The groups receiving different numbers of chemotherapy cycles were not randomized.

Limitations

The sample size was small, and the results should be interpreted with caution.

Participant Demographics

Patients with clinical stage IIIA or IIIB breast cancer.

Statistical Information

P-Value

0.003

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication